Daxor
DXR
4 hedge funds and large institutions have $186K invested in Daxor in 2019 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 0 closing their positions.
33% more funds holding
Funds holding: 3 → 4 (+1)
0.02% less ownership
Funds ownership: 0.55% → 0.53% (-0.02%)
6% less capital invested
Capital invested by funds: $198K → $186K (-$12K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$10.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Prelude Capital Management
New York
|
-$18.2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Renaissance Technologies
New York
| $104K | – | – | – |
|
|
PCM
2
Prelude Capital Management
New York
| $67K | -$18.2K | -1,923 | -21% |
|
|
3
UBS Group
Zurich,
Switzerland
| $11K | +$10.9K | +1,155 | New |
|
4
Wells Fargo
San Francisco,
California
| $4K | – | – | – |
|
DXR Hedge Fund Activity: Q4 2019 in Review
4 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Daxor (DXR) for Q4 2019, worth a combined $186K — down 6.1% from $198K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new DXR positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $10.9K. The largest seller was Prelude Capital Management, cutting an estimated $18.2K.
- 4 institutional investors held Daxor (DXR) as of Q4 2019, up from 3 in Q3 2019.
- Funds reported $186K of Daxor stock for Q4 2019, down 6.1% quarter-over-quarter.
- 1 fund opened new Daxor positions in Q4 2019 and 0 closed out, a net change of +1 holder.
- The largest Daxor buyer in Q4 2019 was UBS Group, an estimated $10.9K added.
- The largest Daxor seller in Q4 2019 was Prelude Capital Management, an estimated $18.2K sold.
Based on aggregated 13F filings for Q4 2019.